D
Teva Pharmaceutical Industries Limited TEVA
$15.38 -$0.07-0.45% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 4.18B 3.89B 4.23B 4.33B 4.16B
Total Other Revenue -- -- -- -- --
Total Revenue 4.18B 3.89B 4.23B 4.33B 4.16B
Cost of Revenue 2.07B 2.01B 2.11B 2.18B 2.14B
Gross Profit 2.10B 1.88B 2.12B 2.15B 2.02B
SG&A Expenses 959.00M 919.00M 952.00M 924.00M 939.00M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses 5.00M 2.00M 28.00M -19.00M -1.00M
Total Operating Expenses 3.28B 3.18B 3.34B 3.33B 3.35B
Operating Income 894.00M 709.00M 893.00M 1.00B 817.00M
Income Before Tax 204.00M 294.00M -247.00M -321.00M -245.00M
Income Tax Expenses -78.00M 74.00M 28.00M 69.00M 630.00M
Earnings from Continuing Operations 282.00M 220.00M -275.00M -390.00M -875.00M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -6.00M 58.00M -47.00M 29.00M
Net Income 282.00M 214.00M -217.00M -437.00M -846.00M
EBIT 894.00M 709.00M 893.00M 1.00B 817.00M
EBITDA 1.15B 953.00M 1.16B 1.26B 1.08B
EPS Basic 0.25 0.19 -0.19 -0.39 -0.75
Normalized Basic EPS 0.35 0.26 0.42 0.36 0.34
EPS Diluted 0.24 0.18 -0.19 -0.39 -0.75
Normalized Diluted EPS 0.35 0.25 0.42 0.36 0.34
Average Basic Shares Outstanding 1.15B 1.14B 1.13B 1.13B 1.13B
Average Diluted Shares Outstanding 1.16B 1.16B 1.13B 1.13B 1.13B
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --